Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by zwerp2000on Dec 17, 2019 4:26pm

65 Views

Post# 30465519

RE:RE:RE:RE:RE:RE:This stock is a disaster

the market for their drug is not as big as you think. it will dwindle over time as there are other treatment alternatives that will prevent the need for this drug. also, if the stock was going to make a huge move based on this drug, it would have already done so. the drug has been around for a while and the stock price continues to do nothing. their nash drug is in a very crowded sector. i doubt they will emerge at the leader

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal